Avixgen is a bio-venture company
on track to becoming a global biopharmaceutical company
for new drug development to improve lives all over the world.

We are a group of passionate and dedicated scientists
that aspire to tackle health challenges that have not yet been solved,
such as macular degeneration, dry-eye disease, and atopic dermatitis.
By utilizing our unique Advanced Cell-Penetrating Peptide (ACP) platform technology,
we are increasing the efficacy of drug delivery in various applications.

Avixgen is committed to discovering innovative drugs and therapeutics
that can better global health, and be a pioneer in the biomedical field.

Thank you for supporting our journey as we aim to realize our potential
as an innovative biopharmaceutical company.